IGF-I Receptor β (D23H3) XP®Rabbit mAb (PE Conjugate)
货号:
8864S 基本售价:
4264.0 元 规格:
100ul
产品信息
概述货号 | 8864S |
描述 | This Cell Signaling Technology antibody is conjugated to phycoerythrin (PE) and tested in-house for direct flow cytometry analysis in human cells. The antibody is expected to exhibit the same species cross-reactivity as the unconjugated IGF-I Receptor β (D23H3) XP® Rabbit mAb #9750. |
反应种属 | Human/Mouse/Rat/Monkey |
来源宿主 | Rabbit |
应用 | F |
目标/特异性 | IGF-I Receptor β (D23H3) XP® Rabbit mAb (PE Conjugate) recognizes endogenous levels of total IGF-I receptor β protein. This antibody does not cross-react with insulin receptor. |
使用方法 | F(1:50) |
性能供应商 | CST |
标记 | PE |
背景 | Type I insulin-like growth factor receptor (IGF-IR) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell lines and cell types within fetal and postnatal tissues (1-3). Receptor autophosphorylation follows binding of the IGF-I and IGF-II ligands. Three tyrosine residues within the kinase domain (Tyr1131, Tyr1135, and Tyr1136) are the earliest major autophosphorylation sites (4). Phosphorylation of these three tyrosine residues is necessary for kinase activation (5,6). Insulin receptors (IRs) share significant structural and functional similarity with IGF-I receptors, including the presence of an equivalent tyrosine cluster (Tyr1146/1150/1151) within the kinase domain activation loop. Tyrosine autophosphorylation of IRs is one of the earliest cellular responses to insulin stimulation (7). Autophosphorylation begins with phosphorylation at Tyr1146 and either Tyr1150 or Tyr1151, while full kinase activation requires triple tyrosine phosphorylation (8). |
存放说明 | 4C |